News

May 24, 2017

END in Africa Project Team Wins Award for Program Excellence

In April 2017, the END in Africa project team was awarded the 2016 Impact Award for Program Excellence. This award recognizes the outstanding contributions of an individual staff member or team to FHI 360’s leadership in global and domestic health, education and development. This contribution may have been demonstrated by promoting integrated development solutions and/or

Read More >

May 2, 2017

Persistent ‘hotspots’ of lymphatic filariasis microfilaraemia despite 14 years of mass drug administration in Ghana

Among the 216 districts in Ghana, 98 were declared endemic for lymphatic filariasis in 1999 after mapping. Pursuing the goal of elimination, WHO recommends annual treatment using mass drugs administration (MDA) for at least 5 years. MDA was started in the country in 2001 and reached national coverage in 2006. By 2014, 69 districts had

Read More >

Twitter

Twitter: ENDinAfrica

About Us

Through the work of its END in Africa and END in Asia programs, FHI 360 is advancing USAID's goal of contributing to the global elimination of NTD by reducing prevalence of seven diseases—lymphatic filariasis (elephantiasis), onchocerciasis (river blindness), schistosomiasis (snail fever), trachoma (blinding eye infection) and three soil-transmitted helminths (hookworm, roundworm, and whipworm).

Find out More >